Evaluation of diagnostic performance of serum copeptin in correlation with dyslipidemia in Obesed and Non-Obesed type 2 diabetes mellitus (T2DM)
Background: High fat in the diet is the main explanations for insulin resistance which will cause type 2 DM (T2DM). Obesity has been known to be related to dyslipidemia which may be a metabolic abnormality resulting in a persistent increase within the plasma concentration of cholesterol and triglyce...
Saved in:
| Published in: | Al Ameen journal of medical sciences Vol. 13; no. 4; pp. 226 - 233 |
|---|---|
| Main Authors: | , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
Al Ameen Medical College
01-10-2020
|
| Subjects: | |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Background: High fat in the diet is the main explanations for insulin resistance which will cause type 2 DM (T2DM). Obesity has been known to be related to dyslipidemia which may be a metabolic abnormality resulting in a persistent increase within the plasma concentration of cholesterol and triglycerides. This study thus aimed in determining the diagnostic role of copeptin and its association with dyslipidemia in obesed and non obesed diabetic subjects. Methods: This research was administered on 50 diabetic subjects and 30 age and sex-matched controls. 5ml of blood was collected from each subject and dispensed into an appropriate anticoagulant bottle. Copeptin and atherogenic indices (Total cholesterol, triglycerides, high density lipoprotein, and low density lipoprotein) were determined using standard laboratory techniques. Statistical analysis of the data was done appropriately and P values less than 0.05 were considered significant. Results: The mean values of copeptin, Total Cholesterol, High Density Lipoprotein, and Low Density Lipoprotein were significantly higher in both Obesed and non-obesed diabetic subjects in comparison to the control group (p<0.05). Also, FBS had a higher area under the ROC curve (AUROC) than copeptin. Conclusion: This study shows that diabetic subjects have higher levels of copeptin and atherogenic indices when it's compared with non-diabetic groups. This actually confirmed that copeptin is related to dyslipidemia which is one among an indicator for top risk of atherogenicity, especially in obesed diabetic subjects that had higher copeptin levels than non-obesed diabetes. Also, copeptin wasn't found to be a more accurate marker of diagnosis for DM when its diagnostic performance with fasting blood glucose decided. |
|---|---|
| ISSN: | 0974-1143 0974-1143 |